Form 8-K - Current report:
SEC Accession No. 0001558370-24-013879
Filing Date
2024-10-30
Accepted
2024-10-30 06:30:18
Documents
15
Period of Report
2024-10-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tech-20241025x8k.htm   iXBRL 8-K 62323
2 EX-99_1 tech-20241025xex99dex991.htm EX-99.EX-99_1 424319
3 EX-99_2 tech-20241025xex99dex992.htm EX-99.EX-99_2 21362
  Complete submission text file 0001558370-24-013879.txt   661423

Data Files

Seq Description Document Type Size
4 EX-101.SCH tech-20241025.xsd EX-101.SCH 3111
5 EX-101.LAB tech-20241025_lab.xml EX-101.LAB 15268
6 EX-101.PRE tech-20241025_pre.xml EX-101.PRE 10907
17 EXTRACTED XBRL INSTANCE DOCUMENT tech-20241025x8k_htm.xml XML 4695
Mailing Address 614 MCKINLEY PLACE NE MINNEAPOLIS MN 55413
Business Address 614 MCKINLEY PL N E MINNEAPOLIS MN 55413 6123798854
BIO-TECHNE Corp (Filer) CIK: 0000842023 (see all company filings)

EIN.: 411427402 | State of Incorp.: MN | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-17272 | Film No.: 241407307
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)